Lara Goldstein

[ad_1] The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances (TCRPS) was created to foster education and research on the field of medical applications of psychedelics, and one…

[ad_1] NYC-based clinics brand Nushama has partnered with Awakn Life Sciences AWKNF, a clinical-stage psychedelics biotech company to bring Awakn’s advanced ketamine-assisted therapy treatment for AUD to Nushama’s New York clinics. They intend…

[ad_1] Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says ‘Potential Reward Is Immeasurable’ Benzinga was the first to report that Brock Pierce, the crypto billionaire, economist and philanthropist serving…

[ad_1] Tuesday’s midterms will give Americans in some states the chance to vote on members of the House of Representatives, Senate and in 36 states, for Governors. In Colorado, voters will decide whether to legalize psychedelics. If…

[ad_1] Psychedelics mental healthcare firm COMPASS Pathways CMPS reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and business…

[ad_1] Psychedelics biotech company Biomind Labs Inc. BMNDF has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT,…

[ad_1] Canadian-based producer of mushroom-derived health supplements Psyched Wellness Ltd. PSYCF has successfully completed the production and delivery of customers’ pre-orders of its Amanita muscaria extraction product, Calm, now shipped across…

[ad_1] Vancouver-based psychedelics biopharma company Apex Labs Ltd. has received Health Canada’s approval to conduct the first North American take-home clinical trial evaluating the safety and efficacy of multiple low…

[ad_1] (Part two of a four-part series) The Palo Santo venture fund invests in private companies. As such, public market movements are not as relevant to them. Nonetheless, these market generations have…

[ad_1] A new research project recently revealed that a child belonging to the Nazca culture in pre-Hispanic Peru ingested a psychoactive plant before being sacrificed as part of a ritual ceremony, reported…

[ad_1] Mental health care company Numinus Wellness NUMIF is re-launching its “Psychedelic Therapy Frontiers” podcast series dedicated to exploring the psychedelics renaissance and cultivating mind, body and spiritual health with…

[ad_1] Ontario Agricultural College’s Department of Plant Agriculture University of Guelph (UG) professors and researchers Dr. Max Jones and Dr. Gale Bozzo received approval by the federal agency Health Canada…

[ad_1] Clinical-stage biopharma company Incannex Healthcare Ltd. IXHL shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S. FDA approvals regarding its…

[ad_1] Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e. ketamine, MDMA, psilocybin, DMT- is regularly paired with psychotherapy by a…

[ad_1] The art world is moving closer to endorsing psychedelics research as witnessed by Nashville-born Daniel Donato’s U.S. concert tour VIP ticket donations. Whether or not you’re familiar with his music, his personal story is truly compelling. As a…

[ad_1] Clinical stage psychedelics company atai Life Sciences ATAI and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing the safety and efficacy of a single…

[ad_1] A five-year license agreement signed between Silo Wellness Inc.’s (OTCQB: SILFF) wholly-owned subsidiary SW Holdings Inc. (SWHI) and Marley Green LLC was terminated by the latter due to the former’s failure to meet its $600,000 in guaranteed minimum royalties…

[ad_1] Nucleus is launching an crowdfunding campaign with the goal of expanding people’s relation with the psychedelics industry. The venture studio subsidiary to VC firm Iter Investments is aiming to impulse psychedelic-assisted therapy forward in the…

[ad_1] Canada is hosting discussions on legal access to psychedelic-assisted therapies, especially after Alberta passed regulatory measures for this type of health service.  So, does this mean that those who could benefit from these…

[ad_1] The 100 Million Ways Foundation (100MW), a not-for-profit organization focused on harm reduction and improving quality of life of those with opioid use disorders, pulled in nearly $100,000 in…

[ad_1] Short-acting psychedelics biotech firm Small Pharma Inc. DMTTF received a USPTO patent protecting the composition matter of a group of deuterated DMT compounds, with expected exclusivity until April 2041.  “We…

[ad_1] Researchers at the University of Texas (UT) Dell Medical School in Austin will use brain scans to examine responses following treatment with psilocybin and 5-MeO-DMT for combatants suffering from…

[ad_1] Silo Pharma Inc. SILO has agreed with Columbia University to an extension of the psychedelics biotech company’s option to license certain treatments currently under development, including Alzheimer’s disease and stress-induced anxiety. The…

[ad_1] Small Pharma Inc. DMTTF, a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31,…

[ad_1] Clinical stage biopharma company atai Life Sciences ATAI announced the initiation of the Phase 1 proof-of-concept (PoC) clinical trial of intranasal INB-01, a sol-gel based, excipient (drug delivery) technology, with topline results expected…